| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.00091 | 1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.00097 | 1 |